<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Hypoxia-driven cancer growth &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/hypoxia-driven-cancer-growth/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 31 Oct 2025 08:16:23 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Hypoxia-driven cancer growth &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>ACSS2 Enhances Ovarian Cancer Cell Growth in Hypoxia</title>
		<link>https://bioengineer.org/acss2-enhances-ovarian-cancer-cell-growth-in-hypoxia/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 31 Oct 2025 08:16:15 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[ACSS2 in ovarian cancer]]></category>
		<category><![CDATA[Cancer cell proliferation under hypoxia]]></category>
		<category><![CDATA[Hypoxia-driven cancer growth]]></category>
		<category><![CDATA[Metabolic reprogramming in hypoxia]]></category>
		<category><![CDATA[Ovarian cancer therapeutic targets]]></category>
		<guid isPermaLink="false">https://bioengineer.org/acss2-enhances-ovarian-cancer-cell-growth-in-hypoxia/</guid>

					<description><![CDATA[A recent study investigating the role of ACSS2 in ovarian cancer cells has revealed startling insights into the mechanisms underpinning cancer proliferation and invasiveness. The research, conducted by Mroweh et al., focused specifically on the hypoxic conditions that characterize many solid tumors. Under such conditions, cancer cells often adapt and evolve, becoming increasingly aggressive and [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">289436</post-id>	</item>
	</channel>
</rss>
